Glyburide Transport Across the Human Placenta
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the magnitude of transplacental transfer of glyburide in women with gestational diabetes mellitus (GDM). METHODS: A prospective, observational study was conducted on women with GDM on glyburide therapy. On delivery admission, the glyburide dose and time of last dose were recorded. Immediately postdelivery, maternal and umbilical venous blood samples were obtained and the concentrations of glyburide were determined by high-performance liquid chromatography-mass spectrometry with a limit of detection of 0.25 ng/mL. RESULTS: Nineteen patient dyads were analyzed. The mean total daily maternal glyburide dose was 6.6±6.3 mg per day and the mean time between last dose and sampling was 13.3±6.5 hours. The mean maternal serum glyburide level at birth was 15.4±20.8 ng/mL, whereas the mean umbilical glyburide level was 7.5±8.2 ng/mL, which showed a statistical correlation (r=0.72, P<.01). There were statistically significant relationships between total maternal glyburide dose (1.25-20 mg per day) and maternal glyburide levels (0.93-70.71 ng/mL; r=0.46, P≤.01) and between total maternal glyburide dose and umbilical glyburide levels (0.95-32.41 ng/mL; r=0.43, P≤.01) However, we observed wide variability in maternal and umbilical glyburide levels at both extremes of the total glyburide dose. Seventy-nine percent of cord samples (15/19) had glyburide levels less than 10 ng/mL (the limit of detection reported in earlier studies) and 37% (7/19) were higher than the corresponding maternal samples. CONCLUSION: Transplacental transfer of glyburide is highly variable among patients, corroborating ex vivo placental perfusion studies showing a transport-mediated glyburide efflux from the fetal to the maternal circulation. In most neonates (79%), glyburide levels were below 10 ng/mL. LEVEL OF EVIDENCE: III.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although glyburide was previously thought not to cross the placenta in significant amounts,61 more recent studies using more sensitive assays have demonstrated significant and highly variable transplacental transfer of glyburide.62,63”
From Gestational Diabetes Mellitus (2019) · cites this paper as [62]
In the citing paper
“Women should be informed that oral agents cross the placenta”
From Gestational Diabetes Mellitus (2019) · cites this paper as [62]
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Diagnosis and Classification of diabetes mellitus
(2014) · Diapedia · doi:10.14496/dia..20 · Cited by 3,214
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
(1998) · PubMed · Cited by 992
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Using methodology with a limit of detection of 10 ng/mL, glyburide was not detected in the cord serum of any neonate.(7) In recent years, a highly sensitive assay for the determination of glyburide at sub-ng/mL concentrations using liquid chromatography–mass spectrometry has been developed and validated.”
MethodPostnatal glucose homeostasis in late-preterm and term infants
Adamkin, D. H., & Committee on Fetus and Newborn (2011) · PEDIATRICS · doi:10.1542/peds.2010-3851 · Cited by 771 · cited 1×
“The definition of neonatal hypoglycemia is highly debated and one single, agreed-on value has not been determined.(20) Two neonates had glucose concentrations less than 40 mg/dL; however, no neonate required admission to the neonatal intensive care unit or intravenous glucose for hypoglycemia.”
BackgroundInsignificant transfer of glyburide occurs across the human placenta
Elliott, B. D., Langer, O., Schenker, S., & Johnson, R. F. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90421-m · Cited by 260
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252 · cited 3×
“Maternal glyburide levels, although clinically therapeutic in terms of glucose control, were lower than what is reported to be therapeutic in nonpregnant individuals, corroborating the findings by Hebert et al.(9) However, the mean maternal glyburide dose was similar to what has been reported to be effective in women…”
MethodResultInfluentialElliott, B. D., Schenker, S., Langer, O., Johnson, R., & Prihoda, T. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90078-7 · Cited by 250 · cited 1×
“Several studies demonstrated negligible transfer, even at glyburide concentrations far exceeding therapeutic levels.(5,6) After the release of these data, Langer and colleagues conducted the first randomized, controlled trial comparing glyburide with insulin in women with GDM.”
Background
Research works printed but not linked: 1
- Brustman, 2011, Hypoglycemia in glyburide-treated gestational diabetes: is it dose dependent Obstet G, ynecol, 117, 349
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Szmuilowicz, E. D., Josefson, J. L., & Metzger, B. E. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.001 · Cited by 364
Short‐ and long‐term outcomes of gestational diabetes and its treatment on fetal development
Murray, S. R., & Reynolds, R. M. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5768 · Cited by 104
“Transplacental transfer is highly variable, but concentrations in new borns are usually very low.(40) It has been shown in a large random-”
BackgroundNachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
“that glyburide does not cross the placenta considerably (1,20), more-recent studies that used more sensitive methods to detect plasma concentrations of glyburide found that glyburide readily crosses the placenta, reaching 50–70% of total maternal plasma concentration with similar average concentrations of maternal and…”
Background
Metadata
- Authors
- Schwartz, R. A., Rosenn, B., Aleksa, K., & Koren, G.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- Venue
- Obstetrics & Gynecology
- Published
- 2015-03
- Volume
- 125
- Issue
- 3
- Pages
- 583-588
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W1967361806
- Cited by
- 83
- References
- 19
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 19 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 9 · 2016: 4 · 2015: 2
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- glibenclamide, transplacental transfer, maternal-fetal drug transfer, gestational diabetes mellitus, umbilical cord blood, neonatal drug exposure
- MeSH terms
- Adult, Female, Fetal Blood, Glyburide, Humans, Hypoglycemic Agents, Maternal-Fetal Exchange, Pregnancy, Prospective Studies, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glyburide Transport Across the Human Placenta. https://app.cochat.ai/papers/10.1097/aog.0000000000000672
- The paper
- Schwartz, R. A., Rosenn, B., Aleksa, K., & Koren, G. (2015). Glyburide Transport Across the Human Placenta. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000000672
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.